

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54889318 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.54889318 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.18449685 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.18449685 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.91946784 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.52633517 |
| 7 | cysteine metabolic process (GO:0006534) | 5.46958460 |
| 8 | urea metabolic process (GO:0019627) | 5.41264456 |
| 9 | urea cycle (GO:0000050) | 5.41264456 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.38027196 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.35754202 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.35754202 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.35754202 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.31224236 |
| 15 | regulation of protein activation cascade (GO:2000257) | 5.27247799 |
| 16 | complement activation, alternative pathway (GO:0006957) | 5.23928676 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.18020052 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 5.12316411 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.11495099 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.00906349 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 4.98410093 |
| 22 | regulation of complement activation (GO:0030449) | 4.96906015 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 4.92036575 |
| 24 | regulation of fibrinolysis (GO:0051917) | 4.90704910 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.89708710 |
| 26 | protein carboxylation (GO:0018214) | 4.89708710 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.77115812 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.75163052 |
| 29 | homocysteine metabolic process (GO:0050667) | 4.72351668 |
| 30 | lysine catabolic process (GO:0006554) | 4.60999445 |
| 31 | lysine metabolic process (GO:0006553) | 4.60999445 |
| 32 | bile acid metabolic process (GO:0008206) | 4.52046936 |
| 33 | tyrosine metabolic process (GO:0006570) | 4.47237436 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.44138866 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.37182663 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.26409362 |
| 37 | glutamate metabolic process (GO:0006536) | 4.26363619 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 4.26247732 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.25074366 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.23861775 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.22982667 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.22982667 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.22982667 |
| 44 | bile acid and bile salt transport (GO:0015721) | 4.17499946 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.10615826 |
| 46 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09502564 |
| 47 | glycine metabolic process (GO:0006544) | 4.05665730 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.04909245 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.04909245 |
| 50 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.01670446 |
| 51 | serine family amino acid metabolic process (GO:0009069) | 3.98000030 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 3.93087768 |
| 53 | phospholipid efflux (GO:0033700) | 3.92974048 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 3.91624410 |
| 55 | cellular amino acid catabolic process (GO:0009063) | 3.89888701 |
| 56 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.89668052 |
| 57 | drug catabolic process (GO:0042737) | 3.83102384 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 3.82223715 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.79267532 |
| 60 | cholesterol efflux (GO:0033344) | 3.78860880 |
| 61 | negative regulation of sterol transport (GO:0032372) | 3.78663608 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 3.78663608 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 3.74248150 |
| 64 | fibrinolysis (GO:0042730) | 3.71227961 |
| 65 | ketone body metabolic process (GO:1902224) | 3.70191915 |
| 66 | coenzyme catabolic process (GO:0009109) | 3.69608544 |
| 67 | low-density lipoprotein particle remodeling (GO:0034374) | 3.68901589 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.67631902 |
| 69 | urate metabolic process (GO:0046415) | 3.65514329 |
| 70 | phospholipid homeostasis (GO:0055091) | 3.65460523 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 3.64086034 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 3.60246886 |
| 73 | cellular glucuronidation (GO:0052695) | 3.60081321 |
| 74 | arginine metabolic process (GO:0006525) | 3.59030811 |
| 75 | complement activation (GO:0006956) | 3.58078355 |
| 76 | regulation of cholesterol homeostasis (GO:2000188) | 3.57790403 |
| 77 | complement activation, classical pathway (GO:0006958) | 3.55779851 |
| 78 | regulation of bile acid biosynthetic process (GO:0070857) | 3.54033921 |
| 79 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.54023675 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.51635256 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 3.51361151 |
| 82 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.48164990 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.48136742 |
| 84 | amine catabolic process (GO:0009310) | 3.48136742 |
| 85 | protein activation cascade (GO:0072376) | 3.44464285 |
| 86 | ethanol oxidation (GO:0006069) | 3.42794204 |
| 87 | epithelial cilium movement (GO:0003351) | 3.42617413 |
| 88 | atrial cardiac muscle cell action potential (GO:0086014) | 3.36912940 |
| 89 | protein-lipid complex assembly (GO:0065005) | 3.34023797 |
| 90 | cilium movement (GO:0003341) | 3.30894356 |
| 91 | aspartate family amino acid catabolic process (GO:0009068) | 3.27668713 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.27328545 |
| 93 | organic acid catabolic process (GO:0016054) | 3.26217306 |
| 94 | carboxylic acid catabolic process (GO:0046395) | 3.26217306 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.25021970 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 3.24961402 |
| 97 | proline transport (GO:0015824) | 3.23886564 |
| 98 | lipoprotein metabolic process (GO:0042157) | 3.23790635 |
| 99 | exogenous drug catabolic process (GO:0042738) | 3.22810682 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.21398569 |
| 101 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.19812365 |
| 102 | sterol homeostasis (GO:0055092) | 3.19724807 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.18869331 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.15593565 |
| 105 | glucuronate metabolic process (GO:0019585) | 3.15593565 |
| 106 | L-fucose metabolic process (GO:0042354) | 3.11042045 |
| 107 | L-fucose catabolic process (GO:0042355) | 3.11042045 |
| 108 | fucose catabolic process (GO:0019317) | 3.11042045 |
| 109 | aldehyde catabolic process (GO:0046185) | 3.10556216 |
| 110 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.09534835 |
| 111 | gamma-aminobutyric acid transport (GO:0015812) | 3.07835320 |
| 112 | cilium morphogenesis (GO:0060271) | 3.04349252 |
| 113 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.93277293 |
| 114 | response to pheromone (GO:0019236) | 2.90705426 |
| 115 | intraciliary transport (GO:0042073) | 2.88580312 |
| 116 | establishment of protein localization to Golgi (GO:0072600) | 2.86946125 |
| 117 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.86221138 |
| 118 | cilium organization (GO:0044782) | 2.84991469 |
| 119 | establishment of nucleus localization (GO:0040023) | 2.82353666 |
| 120 | cilium assembly (GO:0042384) | 2.81905968 |
| 121 | neural tube formation (GO:0001841) | 2.80405155 |
| 122 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.80034322 |
| 123 | kidney morphogenesis (GO:0060993) | 2.79474984 |
| 124 | axoneme assembly (GO:0035082) | 2.79336758 |
| 125 | negative regulation of axon guidance (GO:1902668) | 2.78247213 |
| 126 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.77963543 |
| 127 | limb bud formation (GO:0060174) | 2.72566815 |
| 128 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.67937136 |
| 129 | regulation of protein glycosylation (GO:0060049) | 2.67003801 |
| 130 | signal peptide processing (GO:0006465) | 2.66222002 |
| 131 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.65123350 |
| 132 | nonmotile primary cilium assembly (GO:0035058) | 2.64596757 |
| 133 | retinal ganglion cell axon guidance (GO:0031290) | 2.63512335 |
| 134 | inner ear receptor stereocilium organization (GO:0060122) | 2.63108852 |
| 135 | vascular smooth muscle contraction (GO:0014829) | 2.60515086 |
| 136 | sulfation (GO:0051923) | 2.58796934 |
| 137 | behavioral response to nicotine (GO:0035095) | 2.58034810 |
| 138 | regulation of cilium movement (GO:0003352) | 2.57648995 |
| 139 | platelet dense granule organization (GO:0060155) | 2.57388880 |
| 140 | lymphangiogenesis (GO:0001946) | 2.57255370 |
| 141 | regulation of glucokinase activity (GO:0033131) | 2.56579451 |
| 142 | regulation of hexokinase activity (GO:1903299) | 2.56579451 |
| 143 | nucleus localization (GO:0051647) | 2.56266299 |
| 144 | transmission of nerve impulse (GO:0019226) | 2.54950604 |
| 145 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.54840657 |
| 146 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.54840657 |
| 147 | photoreceptor cell maintenance (GO:0045494) | 2.52836372 |
| 148 | Golgi to endosome transport (GO:0006895) | 2.51475242 |
| 149 | presynaptic membrane assembly (GO:0097105) | 2.50817086 |
| 150 | nucleobase catabolic process (GO:0046113) | 2.50588239 |
| 151 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.45673305 |
| 152 | negative chemotaxis (GO:0050919) | 2.45200551 |
| 153 | protein targeting to Golgi (GO:0000042) | 2.45187459 |
| 154 | auditory receptor cell differentiation (GO:0042491) | 2.44742695 |
| 155 | artery development (GO:0060840) | 2.43693095 |
| 156 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.43193650 |
| 157 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.43139597 |
| 158 | behavioral response to ethanol (GO:0048149) | 2.43124920 |
| 159 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.42920546 |
| 160 | cornea development in camera-type eye (GO:0061303) | 2.42146622 |
| 161 | axonemal dynein complex assembly (GO:0070286) | 2.41267255 |
| 162 | left/right axis specification (GO:0070986) | 2.37717005 |
| 163 | phasic smooth muscle contraction (GO:0014821) | 2.35968984 |
| 164 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.35341815 |
| 165 | regulation of hippo signaling (GO:0035330) | 2.33552082 |
| 166 | negative regulation of protein localization to cell surface (GO:2000009) | 2.31997374 |
| 167 | prenylation (GO:0097354) | 2.30115764 |
| 168 | protein prenylation (GO:0018342) | 2.30115764 |
| 169 | thyroid hormone metabolic process (GO:0042403) | 2.29734183 |
| 170 | detection of light stimulus involved in visual perception (GO:0050908) | 2.28897963 |
| 171 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.28897963 |
| 172 | pericardium development (GO:0060039) | 2.28599775 |
| 173 | cellular response to sterol (GO:0036315) | 2.28031473 |
| 174 | prostate gland growth (GO:0060736) | 2.27328123 |
| 175 | smooth muscle tissue development (GO:0048745) | 2.26708087 |
| 176 | neuronal action potential (GO:0019228) | 2.26564029 |
| 177 | protein K11-linked deubiquitination (GO:0035871) | 2.24105162 |
| 178 | interkinetic nuclear migration (GO:0022027) | 2.23990360 |
| 179 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.23987233 |
| 180 | magnesium ion transport (GO:0015693) | 2.23716342 |
| 181 | smooth muscle contraction (GO:0006939) | 2.22865336 |
| 182 | determination of left/right symmetry (GO:0007368) | 2.22593786 |
| 183 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.22315055 |
| 184 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.22176349 |
| 185 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.22058668 |
| 186 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.21338305 |
| 187 | C4-dicarboxylate transport (GO:0015740) | 2.21101545 |
| 188 | myelin assembly (GO:0032288) | 2.19798362 |
| 189 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.19257204 |
| 190 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.18022552 |
| 191 | dopamine transport (GO:0015872) | 2.17842172 |
| 192 | peristalsis (GO:0030432) | 2.17084472 |
| 193 | presynaptic membrane organization (GO:0097090) | 2.16767647 |
| 194 | nephron epithelium morphogenesis (GO:0072088) | 2.16135633 |
| 195 | nephron tubule morphogenesis (GO:0072078) | 2.16135633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.64457208 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21857946 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.10730776 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.09276895 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.89410275 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.92758696 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.47570060 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.86737129 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.75773807 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67796653 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.35561865 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.22939582 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.18133930 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.12198323 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.09247451 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07071667 |
| 17 | EWS_26573619_Chip-Seq_HEK293_Human | 1.93909430 |
| 18 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.83021574 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75685575 |
| 20 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.72708101 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72250799 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.70183241 |
| 23 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70006481 |
| 24 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.66680598 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63793533 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60538235 |
| 27 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59064300 |
| 28 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.56671510 |
| 29 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.55468727 |
| 30 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.55067010 |
| 31 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.52912885 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52900070 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50790845 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50238553 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.48821056 |
| 36 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.44268410 |
| 37 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.43813573 |
| 38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40810812 |
| 39 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.40763048 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40664771 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39560145 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37505377 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37222976 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35091779 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34797625 |
| 46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34797625 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34083887 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33820961 |
| 49 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.31698310 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.30823438 |
| 51 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28736197 |
| 52 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.28073968 |
| 53 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28053019 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.28046734 |
| 55 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.27482891 |
| 56 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.26866777 |
| 57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25729800 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.24953412 |
| 59 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24283906 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23545982 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22832070 |
| 62 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22005032 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21061826 |
| 64 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21061826 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20975927 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.19988849 |
| 67 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19981806 |
| 68 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19856478 |
| 69 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18599161 |
| 70 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17331683 |
| 71 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17115848 |
| 72 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16705929 |
| 73 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16705929 |
| 74 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15311112 |
| 75 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.14415554 |
| 76 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14378432 |
| 77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13620590 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13535271 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13329055 |
| 80 | JUN_21703547_ChIP-Seq_K562_Human | 1.13185511 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12501888 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11992660 |
| 83 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11804115 |
| 84 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11008457 |
| 85 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10922944 |
| 86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10624379 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10280043 |
| 88 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.09224628 |
| 89 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08574449 |
| 90 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08512468 |
| 91 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06233880 |
| 92 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06045142 |
| 93 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05661100 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04657270 |
| 95 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04657085 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03443518 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02082712 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01979102 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00739940 |
| 100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98360079 |
| 101 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96998493 |
| 102 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94615223 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92757677 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92584108 |
| 105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91746998 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90931956 |
| 107 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.90345195 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90171195 |
| 109 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.89616954 |
| 110 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88010379 |
| 111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86556541 |
| 112 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86380071 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86183697 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85854942 |
| 115 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85112251 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83312098 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83110929 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82324464 |
| 119 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81749393 |
| 120 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.81555564 |
| 121 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.79811303 |
| 122 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78427340 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78196269 |
| 124 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.77662270 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.77353144 |
| 126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76480348 |
| 127 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.76021041 |
| 128 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74992023 |
| 129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.73906268 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.73385846 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.72995121 |
| 132 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.72327971 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.71781255 |
| 134 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.71734067 |
| 135 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71576260 |
| 136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71306786 |
| 137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71021074 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70478295 |
| 139 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.70459345 |
| 140 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.70117118 |
| 141 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.69958422 |
| 142 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.69288602 |
| 143 | * AR_19668381_ChIP-Seq_PC3_Human | 0.68712055 |
| 144 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.66990679 |
| 145 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.66933877 |
| 146 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.65971133 |
| 147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65766429 |
| 148 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.65451233 |
| 149 | CJUN_26792858_Chip-Seq_BT549_Human | 0.64998587 |
| 150 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64039621 |
| 151 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.63575098 |
| 152 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.63374029 |
| 153 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.63374029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.86310059 |
| 2 | MP0005360_urolithiasis | 7.19561761 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.16045592 |
| 4 | MP0005365_abnormal_bile_salt | 5.88972438 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.77344142 |
| 6 | MP0003252_abnormal_bile_duct | 3.95728445 |
| 7 | MP0000569_abnormal_digit_pigmentation | 3.87603288 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.34300872 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.05078958 |
| 10 | MP0005332_abnormal_amino_acid | 2.63547035 |
| 11 | MP0005083_abnormal_biliary_tract | 2.55385972 |
| 12 | MP0009840_abnormal_foam_cell | 2.51873129 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.48604590 |
| 14 | MP0003195_calcinosis | 2.43562844 |
| 15 | MP0003868_abnormal_feces_composition | 2.31622470 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.30580392 |
| 17 | MP0006054_spinal_hemorrhage | 2.19368705 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.13966616 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.12594102 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 2.06005275 |
| 21 | MP0002938_white_spotting | 2.01688831 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.01219162 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.96829803 |
| 24 | MP0002102_abnormal_ear_morphology | 1.93777046 |
| 25 | MP0005171_absent_coat_pigmentation | 1.90408118 |
| 26 | MP0005174_abnormal_tail_pigmentation | 1.89872100 |
| 27 | MP0000609_abnormal_liver_physiology | 1.86538653 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.85738536 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.80690751 |
| 30 | MP0009046_muscle_twitch | 1.78848396 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.76415364 |
| 32 | MP0009697_abnormal_copulation | 1.68867480 |
| 33 | MP0005253_abnormal_eye_physiology | 1.65952012 |
| 34 | MP0000383_abnormal_hair_follicle | 1.65763743 |
| 35 | MP0001984_abnormal_olfaction | 1.65211271 |
| 36 | MP0004885_abnormal_endolymph | 1.64897898 |
| 37 | MP0001485_abnormal_pinna_reflex | 1.64547846 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.62793412 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.56131840 |
| 40 | MP0004043_abnormal_pH_regulation | 1.48800074 |
| 41 | MP0000647_abnormal_sebaceous_gland | 1.47856940 |
| 42 | MP0010678_abnormal_skin_adnexa | 1.43046047 |
| 43 | MP0000778_abnormal_nervous_system | 1.39740260 |
| 44 | MP0001486_abnormal_startle_reflex | 1.38714022 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.37996722 |
| 46 | MP0005451_abnormal_body_composition | 1.37950868 |
| 47 | MP0009053_abnormal_anal_canal | 1.37562217 |
| 48 | MP0003880_abnormal_central_pattern | 1.37291637 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.35402794 |
| 50 | MP0004215_abnormal_myocardial_fiber | 1.35185350 |
| 51 | MP0000631_abnormal_neuroendocrine_gland | 1.35046309 |
| 52 | MP0008877_abnormal_DNA_methylation | 1.33880904 |
| 53 | MP0003937_abnormal_limbs/digits/tail_de | 1.33636564 |
| 54 | MP0005408_hypopigmentation | 1.32675103 |
| 55 | MP0002234_abnormal_pharynx_morphology | 1.30980207 |
| 56 | MP0004142_abnormal_muscle_tone | 1.28302865 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.27292611 |
| 58 | MP0002272_abnormal_nervous_system | 1.26225526 |
| 59 | MP0001299_abnormal_eye_distance/ | 1.23933023 |
| 60 | MP0003136_yellow_coat_color | 1.23324888 |
| 61 | MP0005647_abnormal_sex_gland | 1.20292048 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.19770210 |
| 63 | MP0004924_abnormal_behavior | 1.19770210 |
| 64 | MP0005367_renal/urinary_system_phenotyp | 1.18988441 |
| 65 | MP0000516_abnormal_urinary_system | 1.18988441 |
| 66 | MP0000372_irregular_coat_pigmentation | 1.16623132 |
| 67 | MP0005195_abnormal_posterior_eye | 1.15735260 |
| 68 | MP0002095_abnormal_skin_pigmentation | 1.15014322 |
| 69 | MP0003283_abnormal_digestive_organ | 1.14294913 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14172028 |
| 71 | MP0009745_abnormal_behavioral_response | 1.13557811 |
| 72 | MP0009384_cardiac_valve_regurgitation | 1.13541696 |
| 73 | MP0002751_abnormal_autonomic_nervous | 1.12552898 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.12024479 |
| 75 | MP0005646_abnormal_pituitary_gland | 1.10424070 |
| 76 | MP0002909_abnormal_adrenal_gland | 1.08578255 |
| 77 | MP0004133_heterotaxia | 1.08390820 |
| 78 | MP0002233_abnormal_nose_morphology | 1.08116328 |
| 79 | MP0008775_abnormal_heart_ventricle | 1.07093218 |
| 80 | MP0001501_abnormal_sleep_pattern | 1.06820378 |
| 81 | MP0002254_reproductive_system_inflammat | 1.06729402 |
| 82 | MP0000604_amyloidosis | 1.02468018 |
| 83 | MP0002557_abnormal_social/conspecific_i | 1.02183719 |
| 84 | MP0005248_abnormal_Harderian_gland | 1.01620176 |
| 85 | MP0006276_abnormal_autonomic_nervous | 1.01317992 |
| 86 | MP0001324_abnormal_eye_pigmentation | 1.00947505 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.98065610 |
| 88 | MP0003755_abnormal_palate_morphology | 0.97611079 |
| 89 | MP0004484_altered_response_of | 0.96983526 |
| 90 | MP0004085_abnormal_heartbeat | 0.96915547 |
| 91 | MP0002822_catalepsy | 0.96195360 |
| 92 | MP0000639_abnormal_adrenal_gland | 0.95947196 |
| 93 | MP0004147_increased_porphyrin_level | 0.95758536 |
| 94 | MP0005187_abnormal_penis_morphology | 0.95129608 |
| 95 | MP0003045_fibrosis | 0.94304660 |
| 96 | MP0002090_abnormal_vision | 0.93298407 |
| 97 | MP0000598_abnormal_liver_morphology | 0.92034271 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.91867599 |
| 99 | MP0005503_abnormal_tendon_morphology | 0.90574693 |
| 100 | MP0001661_extended_life_span | 0.90508192 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.89975123 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.89467208 |
| 103 | MP0001286_abnormal_eye_development | 0.89247393 |
| 104 | MP0005395_other_phenotype | 0.89058472 |
| 105 | MP0003329_amyloid_beta_deposits | 0.87138881 |
| 106 | MP0002160_abnormal_reproductive_system | 0.87054067 |
| 107 | MP0002184_abnormal_innervation | 0.87026233 |
| 108 | MP0002572_abnormal_emotion/affect_behav | 0.86822254 |
| 109 | MP0005391_vision/eye_phenotype | 0.86818977 |
| 110 | MP0002752_abnormal_somatic_nervous | 0.86727634 |
| 111 | MP0002282_abnormal_trachea_morphology | 0.86490552 |
| 112 | MP0001764_abnormal_homeostasis | 0.86203275 |
| 113 | MP0003935_abnormal_craniofacial_develop | 0.86086831 |
| 114 | MP0004130_abnormal_muscle_cell | 0.85657181 |
| 115 | MP0000026_abnormal_inner_ear | 0.85207521 |
| 116 | MP0002067_abnormal_sensory_capabilities | 0.85136514 |
| 117 | MP0001293_anophthalmia | 0.83814403 |
| 118 | MP0002229_neurodegeneration | 0.82563048 |
| 119 | MP0003718_maternal_effect | 0.82068134 |
| 120 | MP0002653_abnormal_ependyma_morphology | 0.81683632 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.78349511 |
| 122 | MP0002168_other_aberrant_phenotype | 0.77893474 |
| 123 | MP0003690_abnormal_glial_cell | 0.74035805 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.72459661 |
| 125 | MP0005636_abnormal_mineral_homeostasis | 0.71296621 |
| 126 | MP0001756_abnormal_urination | 0.67000079 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.66766382 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.66257769 |
| 129 | MP0002971_abnormal_brown_adipose | 0.66235232 |
| 130 | MP0002928_abnormal_bile_duct | 0.64858622 |
| 131 | MP0003186_abnormal_redox_activity | 0.64419016 |
| 132 | MP0002876_abnormal_thyroid_physiology | 0.63912541 |
| 133 | MP0009764_decreased_sensitivity_to | 0.62763077 |
| 134 | MP0004185_abnormal_adipocyte_glucose | 0.61758179 |
| 135 | MP0005535_abnormal_body_temperature | 0.61060052 |
| 136 | MP0004858_abnormal_nervous_system | 0.60256347 |
| 137 | MP0003011_delayed_dark_adaptation | 0.59465243 |
| 138 | MP0009763_increased_sensitivity_to | 0.58644373 |
| 139 | MP0005220_abnormal_exocrine_pancreas | 0.57350110 |
| 140 | MP0009642_abnormal_blood_homeostasis | 0.57193059 |
| 141 | MP0002837_dystrophic_cardiac_calcinosis | 0.56982443 |
| 142 | MP0001968_abnormal_touch/_nociception | 0.56205450 |
| 143 | MP0009672_abnormal_birth_weight | 0.55482846 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.54445193 |
| 145 | MP0004883_abnormal_blood_vessel | 0.54397157 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.53357387 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.52500421 |
| 148 | MP0000579_abnormal_nail_morphology | 0.52014222 |
| 149 | MP0005334_abnormal_fat_pad | 0.51400580 |
| 150 | MP0008874_decreased_physiological_sensi | 0.48125101 |
| 151 | MP0000538_abnormal_urinary_bladder | 0.47793478 |
| 152 | MP0004859_abnormal_synaptic_plasticity | 0.47665340 |
| 153 | MP0001915_intracranial_hemorrhage | 0.47320224 |
| 154 | MP0003123_paternal_imprinting | 0.44780850 |
| 155 | MP0008872_abnormal_physiological_respon | 0.44689802 |
| 156 | MP0004270_analgesia | 0.43982587 |
| 157 | MP0005448_abnormal_energy_balance | 0.43105336 |
| 158 | MP0002736_abnormal_nociception_after | 0.42118928 |
| 159 | MP0003699_abnormal_female_reproductive | 0.41017626 |
| 160 | MP0001177_atelectasis | 0.40540732 |
| 161 | MP0003632_abnormal_nervous_system | 0.39741568 |
| 162 | MP0003638_abnormal_response/metabolism_ | 0.39539278 |
| 163 | MP0003953_abnormal_hormone_level | 0.39409101 |
| 164 | MP0005670_abnormal_white_adipose | 0.38661825 |
| 165 | MP0006138_congestive_heart_failure | 0.37993479 |
| 166 | MP0004272_abnormal_basement_membrane | 0.37618932 |
| 167 | MP0005197_abnormal_uvea_morphology | 0.36685151 |
| 168 | MP0009765_abnormal_xenobiotic_induced | 0.36565624 |
| 169 | MP0000427_abnormal_hair_cycle | 0.36481676 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.36125269 |
| 171 | MP0001340_abnormal_eyelid_morphology | 0.35343878 |
| 172 | MP0005266_abnormal_metabolism | 0.35077915 |
| 173 | MP0002295_abnormal_pulmonary_circulatio | 0.34218212 |
| 174 | MP0003633_abnormal_nervous_system | 0.33876399 |
| 175 | MP0001440_abnormal_grooming_behavior | 0.33416765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.26724461 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.68053397 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.04471259 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.89351942 |
| 5 | Xanthomatosis (HP:0000991) | 5.83169937 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.67224594 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.59545446 |
| 8 | Complement deficiency (HP:0004431) | 5.38974798 |
| 9 | Hyperglycinemia (HP:0002154) | 4.49472045 |
| 10 | Epidermoid cyst (HP:0200040) | 4.48838952 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.46749257 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.46729859 |
| 13 | Pancreatic fibrosis (HP:0100732) | 4.23684531 |
| 14 | Pancreatic cysts (HP:0001737) | 4.21505288 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 4.14635439 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14375374 |
| 17 | Joint hemorrhage (HP:0005261) | 4.02049825 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.95302323 |
| 19 | Hyperammonemia (HP:0001987) | 3.94031536 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.92248625 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.87388274 |
| 22 | True hermaphroditism (HP:0010459) | 3.86335039 |
| 23 | Abnormality of midbrain morphology (HP:0002418) | 3.83209747 |
| 24 | Molar tooth sign on MRI (HP:0002419) | 3.83209747 |
| 25 | Abnormality of complement system (HP:0005339) | 3.81210204 |
| 26 | Hyperglycinuria (HP:0003108) | 3.79981675 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.70798323 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.70798323 |
| 29 | Abnormality of the renal cortex (HP:0011035) | 3.66739861 |
| 30 | Ketosis (HP:0001946) | 3.65052215 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.61801654 |
| 32 | Fat malabsorption (HP:0002630) | 3.56595313 |
| 33 | Hypochromic microcytic anemia (HP:0004840) | 3.55596694 |
| 34 | Nephronophthisis (HP:0000090) | 3.54622522 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.53616378 |
| 36 | Abnormality of the renal medulla (HP:0100957) | 3.42893114 |
| 37 | Hepatocellular carcinoma (HP:0001402) | 3.42458329 |
| 38 | Tubular atrophy (HP:0000092) | 3.41174709 |
| 39 | Spontaneous abortion (HP:0005268) | 3.40069851 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32446155 |
| 41 | Chronic hepatic failure (HP:0100626) | 3.21712350 |
| 42 | Medial flaring of the eyebrow (HP:0010747) | 3.20912919 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 3.16644760 |
| 44 | Myocardial infarction (HP:0001658) | 3.15302714 |
| 45 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.06678384 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.04168209 |
| 47 | Hypothermia (HP:0002045) | 2.97466750 |
| 48 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.97337867 |
| 49 | Acanthocytosis (HP:0001927) | 2.93761579 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.93306145 |
| 51 | Sensorimotor neuropathy (HP:0007141) | 2.88679093 |
| 52 | Type II lissencephaly (HP:0007260) | 2.87019285 |
| 53 | Skin nodule (HP:0200036) | 2.83844272 |
| 54 | Gout (HP:0001997) | 2.82135186 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.80362754 |
| 56 | Large for gestational age (HP:0001520) | 2.72716714 |
| 57 | Keratoconus (HP:0000563) | 2.67958793 |
| 58 | Increased corneal curvature (HP:0100692) | 2.67958793 |
| 59 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.66806547 |
| 60 | Gait imbalance (HP:0002141) | 2.66460720 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.65477297 |
| 62 | Ketoacidosis (HP:0001993) | 2.65100272 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.64555188 |
| 64 | Hyperbilirubinemia (HP:0002904) | 2.59582628 |
| 65 | Congenital primary aphakia (HP:0007707) | 2.57482425 |
| 66 | Gaze-evoked nystagmus (HP:0000640) | 2.50460340 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.50113613 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.49547011 |
| 69 | Cystic liver disease (HP:0006706) | 2.48128591 |
| 70 | Febrile seizures (HP:0002373) | 2.47059111 |
| 71 | Glomerulonephritis (HP:0000099) | 2.45810785 |
| 72 | Abnormal ciliary motility (HP:0012262) | 2.45801863 |
| 73 | Neuroendocrine neoplasm (HP:0100634) | 2.45493515 |
| 74 | Spastic diplegia (HP:0001264) | 2.45139323 |
| 75 | Status epilepticus (HP:0002133) | 2.43261051 |
| 76 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.42087408 |
| 77 | Neonatal onset (HP:0003623) | 2.41457044 |
| 78 | Esophageal varix (HP:0002040) | 2.40052022 |
| 79 | Nephrogenic diabetes insipidus (HP:0009806) | 2.39507176 |
| 80 | Furrowed tongue (HP:0000221) | 2.39046865 |
| 81 | Cholelithiasis (HP:0001081) | 2.38070730 |
| 82 | Congenital sensorineural hearing impairment (HP:0008527) | 2.37476889 |
| 83 | Genital tract atresia (HP:0001827) | 2.36861574 |
| 84 | Renal cortical cysts (HP:0000803) | 2.36488824 |
| 85 | Steatorrhea (HP:0002570) | 2.36129612 |
| 86 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.35565212 |
| 87 | Congenital hepatic fibrosis (HP:0002612) | 2.33592852 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.33112589 |
| 89 | Abnormal drinking behavior (HP:0030082) | 2.30672467 |
| 90 | Polydipsia (HP:0001959) | 2.30672467 |
| 91 | Occipital encephalocele (HP:0002085) | 2.28854759 |
| 92 | Rhinitis (HP:0012384) | 2.28421127 |
| 93 | Poikilocytosis (HP:0004447) | 2.27733781 |
| 94 | Cerebellar dysplasia (HP:0007033) | 2.26600931 |
| 95 | Chorioretinal atrophy (HP:0000533) | 2.25126267 |
| 96 | Vaginal atresia (HP:0000148) | 2.24884126 |
| 97 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.24452723 |
| 98 | Absent/shortened dynein arms (HP:0200106) | 2.24452723 |
| 99 | Malnutrition (HP:0004395) | 2.21818217 |
| 100 | Hyperglycemia (HP:0003074) | 2.21172188 |
| 101 | Abnormality of the ischium (HP:0003174) | 2.20205809 |
| 102 | Broad-based gait (HP:0002136) | 2.19707923 |
| 103 | Confusion (HP:0001289) | 2.18843551 |
| 104 | Postaxial hand polydactyly (HP:0001162) | 2.17995888 |
| 105 | Mitral stenosis (HP:0001718) | 2.16098444 |
| 106 | Cholecystitis (HP:0001082) | 2.15077802 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 2.15077802 |
| 108 | Absent speech (HP:0001344) | 2.14801503 |
| 109 | Postaxial foot polydactyly (HP:0001830) | 2.14096744 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.12440739 |
| 111 | Intestinal atresia (HP:0011100) | 2.10154781 |
| 112 | Widely spaced teeth (HP:0000687) | 2.10146047 |
| 113 | Sclerocornea (HP:0000647) | 2.09545177 |
| 114 | Irritability (HP:0000737) | 2.08972044 |
| 115 | Congenital stationary night blindness (HP:0007642) | 2.08591374 |
| 116 | Short tibia (HP:0005736) | 2.08566068 |
| 117 | Hypoplastic labia majora (HP:0000059) | 2.08490926 |
| 118 | Tubulointerstitial abnormality (HP:0001969) | 2.08190330 |
| 119 | Vascular calcification (HP:0004934) | 2.07413892 |
| 120 | Metabolic acidosis (HP:0001942) | 2.04049073 |
| 121 | Lethargy (HP:0001254) | 2.00995321 |
| 122 | Abnormal biliary tract physiology (HP:0012439) | 2.00591208 |
| 123 | Bile duct proliferation (HP:0001408) | 2.00591208 |
| 124 | Poor coordination (HP:0002370) | 2.00455558 |
| 125 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.99167104 |
| 126 | Bifid tongue (HP:0010297) | 1.98848269 |
| 127 | Tubulointerstitial nephritis (HP:0001970) | 1.97617229 |
| 128 | Cardiovascular calcification (HP:0011915) | 1.97183620 |
| 129 | Thyroid-stimulating hormone excess (HP:0002925) | 1.97174704 |
| 130 | Abnormality of the Achilles tendon (HP:0005109) | 1.96976120 |
| 131 | Global brain atrophy (HP:0002283) | 1.96023799 |
| 132 | Hyperventilation (HP:0002883) | 1.95129685 |
| 133 | Volvulus (HP:0002580) | 1.93817290 |
| 134 | Polyuria (HP:0000103) | 1.93577188 |
| 135 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.91025734 |
| 136 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.91025734 |
| 137 | Hypoplastic ischia (HP:0003175) | 1.89089558 |
| 138 | Abnormality of the gallbladder (HP:0005264) | 1.87931483 |
| 139 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87470012 |
| 140 | Abnormality of the labia majora (HP:0012881) | 1.86786047 |
| 141 | Amyloidosis (HP:0011034) | 1.86148140 |
| 142 | Attenuation of retinal blood vessels (HP:0007843) | 1.86081997 |
| 143 | Abnormal pancreas size (HP:0012094) | 1.84724997 |
| 144 | Hemorrhage of the eye (HP:0011885) | 1.84692512 |
| 145 | Hypoglycemic seizures (HP:0002173) | 1.83335763 |
| 146 | Tubulointerstitial fibrosis (HP:0005576) | 1.83273226 |
| 147 | Male pseudohermaphroditism (HP:0000037) | 1.83160602 |
| 148 | Nephritis (HP:0000123) | 1.82774295 |
| 149 | Narrow forehead (HP:0000341) | 1.82755040 |
| 150 | Increased purine levels (HP:0004368) | 1.81296046 |
| 151 | Hyperuricemia (HP:0002149) | 1.81296046 |
| 152 | Genetic anticipation (HP:0003743) | 1.78702766 |
| 153 | Fair hair (HP:0002286) | 1.78590192 |
| 154 | Rickets (HP:0002748) | 1.78468706 |
| 155 | Enlarged kidneys (HP:0000105) | 1.78447059 |
| 156 | Drooling (HP:0002307) | 1.77632572 |
| 157 | Abnormality of the lower motor neuron (HP:0002366) | 1.77592996 |
| 158 | Anencephaly (HP:0002323) | 1.77586680 |
| 159 | Upper motor neuron abnormality (HP:0002127) | 1.77525650 |
| 160 | Reticulocytosis (HP:0001923) | 1.75987942 |
| 161 | Short foot (HP:0001773) | 1.75378504 |
| 162 | Turricephaly (HP:0000262) | 1.72659244 |
| 163 | Abnormality of proline metabolism (HP:0010907) | 1.72602305 |
| 164 | Hydroxyprolinuria (HP:0003080) | 1.72602305 |
| 165 | Abolished electroretinogram (ERG) (HP:0000550) | 1.72006809 |
| 166 | Atonic seizures (HP:0010819) | 1.71853237 |
| 167 | Generalized hypopigmentation of hair (HP:0011358) | 1.71753074 |
| 168 | Inability to walk (HP:0002540) | 1.71032407 |
| 169 | Oculomotor apraxia (HP:0000657) | 1.70410598 |
| 170 | Abnormal cartilage morphology (HP:0002763) | 1.69789640 |
| 171 | Anophthalmia (HP:0000528) | 1.69174565 |
| 172 | Small hand (HP:0200055) | 1.68561464 |
| 173 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.67846728 |
| 174 | Lissencephaly (HP:0001339) | 1.67202888 |
| 175 | Blue irides (HP:0000635) | 1.67169751 |
| 176 | Hemiparesis (HP:0001269) | 1.67167123 |
| 177 | Preaxial foot polydactyly (HP:0001841) | 1.67019089 |
| 178 | Median cleft lip (HP:0000161) | 1.66835555 |
| 179 | Pheochromocytoma (HP:0002666) | 1.66525052 |
| 180 | Labial hypoplasia (HP:0000066) | 1.66346581 |
| 181 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.65269907 |
| 182 | Termporal pattern (HP:0011008) | 1.64358507 |
| 183 | Insidious onset (HP:0003587) | 1.64358507 |
| 184 | Cortical dysplasia (HP:0002539) | 1.64320595 |
| 185 | Thrombophlebitis (HP:0004418) | 1.63708470 |
| 186 | Back pain (HP:0003418) | 1.63519137 |
| 187 | Progressive inability to walk (HP:0002505) | 1.63271132 |
| 188 | Progressive cerebellar ataxia (HP:0002073) | 1.63204248 |
| 189 | Optic nerve hypoplasia (HP:0000609) | 1.63003460 |
| 190 | Tetraplegia (HP:0002445) | 1.61656261 |
| 191 | Cerebral edema (HP:0002181) | 1.61607984 |
| 192 | Abnormality of macular pigmentation (HP:0008002) | 1.61586451 |
| 193 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.60657779 |
| 194 | Dicarboxylic aciduria (HP:0003215) | 1.60657779 |
| 195 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.60475989 |
| 196 | Short hallux (HP:0010109) | 1.58459152 |
| 197 | Preaxial hand polydactyly (HP:0001177) | 1.57387979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 5.59182432 |
| 2 | LATS2 | 4.22184082 |
| 3 | BMPR1B | 3.95007177 |
| 4 | ERBB4 | 3.00276603 |
| 5 | STK38L | 2.97307479 |
| 6 | ACVR1B | 2.63165176 |
| 7 | MAP2K4 | 2.59428283 |
| 8 | TNIK | 2.32133589 |
| 9 | MAP3K4 | 2.29440939 |
| 10 | FRK | 2.28627160 |
| 11 | KSR2 | 2.10406268 |
| 12 | SIK1 | 2.09210431 |
| 13 | MST1R | 2.06697095 |
| 14 | STK39 | 2.01969920 |
| 15 | ADRBK2 | 2.01092440 |
| 16 | DAPK2 | 1.99730936 |
| 17 | EPHA4 | 1.92996556 |
| 18 | ABL2 | 1.90257894 |
| 19 | TRIM28 | 1.89891666 |
| 20 | BCKDK | 1.87543458 |
| 21 | MAP3K9 | 1.78726841 |
| 22 | PINK1 | 1.76731354 |
| 23 | CAMK1D | 1.74648383 |
| 24 | MAP4K2 | 1.73836908 |
| 25 | STK3 | 1.66480601 |
| 26 | TAOK3 | 1.65925054 |
| 27 | BCR | 1.59420269 |
| 28 | NTRK1 | 1.57016768 |
| 29 | STK38 | 1.54230368 |
| 30 | GRK1 | 1.46418518 |
| 31 | NTRK3 | 1.43910780 |
| 32 | WNK4 | 1.43052860 |
| 33 | PKN2 | 1.42998213 |
| 34 | EIF2AK3 | 1.39842948 |
| 35 | MAPK13 | 1.38088764 |
| 36 | FGFR4 | 1.36574017 |
| 37 | RET | 1.34548950 |
| 38 | ERBB3 | 1.33771060 |
| 39 | NEK9 | 1.33010631 |
| 40 | MAP3K12 | 1.32958960 |
| 41 | MARK1 | 1.29324709 |
| 42 | MKNK2 | 1.26752549 |
| 43 | CAMK1G | 1.26083030 |
| 44 | TRIB3 | 1.25776150 |
| 45 | INSRR | 1.25593856 |
| 46 | OXSR1 | 1.24787589 |
| 47 | PAK6 | 1.24685796 |
| 48 | PRKCE | 1.23217866 |
| 49 | SGK2 | 1.22203975 |
| 50 | MAP3K6 | 1.19592350 |
| 51 | PDGFRA | 1.16978483 |
| 52 | MET | 1.14284783 |
| 53 | MAP3K2 | 1.13904714 |
| 54 | KSR1 | 1.11433320 |
| 55 | MYLK | 1.10953252 |
| 56 | FGFR2 | 1.09340983 |
| 57 | SGK3 | 1.08872002 |
| 58 | ADRBK1 | 1.00748891 |
| 59 | AKT3 | 1.00650646 |
| 60 | GRK5 | 0.99194800 |
| 61 | MAPK15 | 0.97554357 |
| 62 | STK16 | 0.97193271 |
| 63 | EPHA3 | 0.96632416 |
| 64 | MAP2K7 | 0.96468091 |
| 65 | TGFBR2 | 0.94554705 |
| 66 | CSNK1G2 | 0.91123517 |
| 67 | ERN1 | 0.90745161 |
| 68 | MAPK11 | 0.90275471 |
| 69 | IRAK1 | 0.89484899 |
| 70 | RIPK1 | 0.88628303 |
| 71 | BRSK2 | 0.88357306 |
| 72 | CSNK1G1 | 0.86943387 |
| 73 | PRKAA2 | 0.86679609 |
| 74 | PTK2 | 0.85140631 |
| 75 | MAP2K1 | 0.84836827 |
| 76 | CDK12 | 0.83850615 |
| 77 | DMPK | 0.83678052 |
| 78 | TIE1 | 0.83160540 |
| 79 | SGK223 | 0.82072739 |
| 80 | SGK494 | 0.82072739 |
| 81 | RAF1 | 0.81997486 |
| 82 | ERBB2 | 0.81759252 |
| 83 | MST4 | 0.80615006 |
| 84 | PRKAA1 | 0.80363398 |
| 85 | TYRO3 | 0.79618728 |
| 86 | PLK2 | 0.78659849 |
| 87 | CAMKK1 | 0.78040151 |
| 88 | NUAK1 | 0.76580096 |
| 89 | SCYL2 | 0.75341851 |
| 90 | TRPM7 | 0.74398144 |
| 91 | TGFBR1 | 0.74281533 |
| 92 | FER | 0.74193157 |
| 93 | EIF2AK1 | 0.73847894 |
| 94 | WNK3 | 0.73521436 |
| 95 | NLK | 0.72421975 |
| 96 | PIK3CG | 0.72212309 |
| 97 | CAMKK2 | 0.71662119 |
| 98 | PAK3 | 0.71492842 |
| 99 | PHKG1 | 0.71196491 |
| 100 | PHKG2 | 0.71196491 |
| 101 | STK24 | 0.70897303 |
| 102 | ZAK | 0.70169024 |
| 103 | PRKCZ | 0.69319071 |
| 104 | CDK6 | 0.68801683 |
| 105 | ROCK1 | 0.68328726 |
| 106 | WNK1 | 0.68112743 |
| 107 | PDPK1 | 0.66207289 |
| 108 | MINK1 | 0.65287081 |
| 109 | NEK1 | 0.62010818 |
| 110 | JAK2 | 0.61561929 |
| 111 | DDR2 | 0.60448973 |
| 112 | MELK | 0.60230153 |
| 113 | BMX | 0.60183642 |
| 114 | PRKCG | 0.59667064 |
| 115 | CDK3 | 0.57402924 |
| 116 | MUSK | 0.57325593 |
| 117 | MAP3K5 | 0.56381158 |
| 118 | PRKG1 | 0.53882330 |
| 119 | WEE1 | 0.53861304 |
| 120 | TAOK1 | 0.52732592 |
| 121 | PDGFRB | 0.51338993 |
| 122 | PTK6 | 0.51262292 |
| 123 | CASK | 0.50881545 |
| 124 | PLK3 | 0.50771867 |
| 125 | OBSCN | 0.48072027 |
| 126 | FLT3 | 0.47600597 |
| 127 | GSK3A | 0.45963355 |
| 128 | EPHB2 | 0.45257623 |
| 129 | CSNK1G3 | 0.43022332 |
| 130 | DYRK1A | 0.42267743 |
| 131 | NTRK2 | 0.41948860 |
| 132 | PTK2B | 0.41021539 |
| 133 | MTOR | 0.40014799 |
| 134 | PDK3 | 0.39606841 |
| 135 | PDK4 | 0.39606841 |
| 136 | FGFR1 | 0.39376977 |
| 137 | PRKACB | 0.39362479 |
| 138 | SGK1 | 0.39264296 |
| 139 | CSNK1E | 0.39165590 |
| 140 | CAMK2D | 0.39019691 |
| 141 | RPS6KA3 | 0.38458376 |
| 142 | IGF1R | 0.37628453 |
| 143 | LMTK2 | 0.37628414 |
| 144 | PIK3CA | 0.37541606 |
| 145 | STK11 | 0.37261295 |
| 146 | PRKACG | 0.36695212 |
| 147 | MOS | 0.36463029 |
| 148 | YES1 | 0.36061643 |
| 149 | MAPK10 | 0.35962951 |
| 150 | CSNK1A1L | 0.35394402 |
| 151 | PRKACA | 0.34839867 |
| 152 | MKNK1 | 0.34301618 |
| 153 | FGFR3 | 0.34064241 |
| 154 | PDK1 | 0.33563343 |
| 155 | PNCK | 0.32427269 |
| 156 | BRAF | 0.32074038 |
| 157 | CAMK2A | 0.30684496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.58647893 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.33599082 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38228969 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.25405091 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15687530 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86555913 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55647916 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51777103 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50947647 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41071073 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27007846 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19801112 |
| 13 | Protein export_Homo sapiens_hsa03060 | 2.13781971 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11468254 |
| 15 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.06924549 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.00644293 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85539943 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82733668 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77731103 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.75846477 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.74765257 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74538486 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.74345930 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.71488110 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.69148330 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.68953246 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63840741 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61852787 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57422628 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.56040118 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55932982 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.54074929 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53353132 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.50652365 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50257220 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46295471 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44766527 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.44518892 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42198038 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40947335 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38251743 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.33897327 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32752570 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.30900084 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30213188 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.30141396 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 1.27347494 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26972107 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26501401 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.26097663 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23768114 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22553165 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21542059 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19939121 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19058353 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 1.18702877 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16710577 |
| 58 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14209412 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13294603 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10180056 |
| 61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.07783902 |
| 62 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.04477942 |
| 63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03197018 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01658872 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 1.01046602 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99598887 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98296223 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95366470 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95177474 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94973276 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.92503344 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91228324 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89132383 |
| 74 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89124526 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87737526 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86757830 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85910142 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84380862 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82846831 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81099900 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.79840846 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.79797558 |
| 83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77802851 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.77773599 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77018631 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72888057 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71715285 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69137282 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68416349 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68066204 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64910692 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64857426 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.64558914 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64291664 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.62968437 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62181238 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.61262802 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56669217 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55706855 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55403001 |
| 101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.53254447 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52172678 |
| 103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50814105 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50519736 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.49947579 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49764365 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.49314799 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47559888 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47287860 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44824816 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42089116 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41968949 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41043120 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39927540 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35774266 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.35146064 |
| 117 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34452828 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30817386 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28501680 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.28382915 |
| 121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27908556 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27888125 |
| 123 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.26710465 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25186889 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24171308 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18689587 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16698903 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15306101 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.13056001 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.11483595 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09731422 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.07632106 |
| 133 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.06145460 |
| 134 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.05134502 |
| 135 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.04763012 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.04398511 |
| 137 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.03932741 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.03868465 |
| 139 | Glioma_Homo sapiens_hsa05214 | 0.03754237 |
| 140 | GABAergic synapse_Homo sapiens_hsa04727 | 0.03107265 |
| 141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.02635419 |
| 142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.02243597 |
| 143 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.02233174 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.01632937 |
| 145 | Amoebiasis_Homo sapiens_hsa05146 | 0.00889288 |
| 146 | Renin secretion_Homo sapiens_hsa04924 | -0.0135458 |
| 147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0120154 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0088087 |
| 149 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0069132 |
| 150 | Bladder cancer_Homo sapiens_hsa05219 | -0.0052199 |

